We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Meritage Homes (MTH) Q4 Earnings Beat Estimates, Shares Up
Read MoreHide Full Article
Meritage Homes Corporation’s (MTH - Free Report) shares increased more than 7% in the after-hour trading session on Jan 29, post the company reported better-than-expected earnings in fourth-quarter 2019.
Earnings of $2.65 per share topped the Zacks Consensus Estimate of $1.92 by an impressive 38%. Also, the reported figure improved 39% year over year backed by solid home closing revenues, gross margins and greater overhead leverage. It also benefitted from retroactive energy tax credits recorded in 2019.
Total revenues (including Homebuilding and Financial Services revenues) amounted to $1,141.6 million, up 12.7% from year-ago quarter’s levels.
Meritage Homes Corporation Price, Consensus and EPS Surprise
Homebuilding/Total Closing Revenues: Revenues in the segment increased 12.7% from the prior-year quarter’s level to $1,136.8 million. Home closing revenues during the quarter amounted to $1,103.7 million, up 10.8% year over year. The upside can be attributed to a 13% increase in volumes, partially offset by 2% reduction in average sales price or ASP due to its strategic shift toward more affordable homes.
Home closing revenues in the East and West regions were both up by 19% year over year. However, Central declined 8% year over year primarily due to lower communities opening in the reporetd quarter.
Homes closed during the fourth quarter came in at 2,830, up 13% year over year. Total orders increased 26.6% from the prior-year quarter’s levels to 2,093 homes, marking it strongest quarterly year-over-year growth. The value of net orders also increased 24.8% year over year to $804.1 million mainly due to 37% higher absorption rate backed by rise in demand for its entry-level priced LiVE.NOW. homes.
However average community count fell 8% year on year, owing to early close-outs of communities in 2019. Active communities as of Dec 31, 2019 were 244, down from 272 homes reported in the year-ago quarter. Backlog at the end of the quarter totaled 2,782 units, up 14.3% year over year. Value of these backlogs also increased 8.1% year over year.
Home closing gross margin during the fourth quarter increased 80 basis points (bps) to 19.8% from year-ago quarter’s figure of 19%. This marked a contribution of 16% year-over-year increase to total home closing gross profit.
Moreover, land closing revenues amounted to $33.1 million, up 160% from $12.7 million in the year-ago quarter.
Financial Services: The segment’s revenues increased 7.8% from the prior-year quarter’s level to $4.7 million.
Operating Highlights
Selling, general and administrative expenses (as a percentage of home closing revenues) of 10.1% declined 50 bps from the prior-year quarter’s level of 10.6%.
Balance Sheet
As of Dec 31, 2019, cash and cash equivalents totaled $319.5 million compared with $311.5 million on Dec 31, 2018.
Debt-to-capital ratio at the end of 2019 was 34% compared with 43.2% at 2018-end. Also, net debt-to-capital ratio contracted to 26.2% from 36.7% on Dec 31, 2018.
2019 Highlights
Earnings per share for the year ended Dec 31, 2019 was reported at $6.42, up 15.1% from $5.58 reported in 2018.
Home closing gross margin increased 70 bps to 18.9% from 18.2% in 2018.
Total orders increased 19% year over year on the back of 37.3% increase in absorptions.
2020 Guidance
Given the company’s ability to deliver great value homes at modest prices along with positive economic drivers surrounding the housing market, the company is optimistic about future growth and success. It expects earnings to increase faster than its top-line growth in 2020, leveraging the operating improvements that were made earlier with further expansion and refinement.
For 2020, the company expects total home closings in the range of 9,700-10,200 units that suggests an increase from 9,267 units reported on Dec 31, 2019. Also, Meritage Homes expects ASPs in the range of $360,000 -370,000 that indicates a rise from $389,000 reported last year. Home closing gross margin is expected in the mid-19 percent, while tax rate is expected at approximately 22%.
KB Home (KBH - Free Report) reported fourth-quarter fiscal 2019 results, with earnings beating analysts’ expectation and revenues missing the same. The quarterly results primarily benefited from strong demand for its built-to-order products at affordable price points along with higher deliveries. Moreover, the company’s top and the bottom line increased year over year by 15.6% and 36%, respectively.
D.R. Horton, Inc. (DHI - Free Report) reported first-quarter fiscal 2020 results, with earnings and revenues beating respective Zacks Consensus Estimate. Solid demand, limited supply of homes at affordable prices across the markets served, favorable economic fundamentals and financing availability. Also, 30,200 homes in inventory (at the end of December) make D.R. Horton well positioned for the spring selling season.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Meritage Homes (MTH) Q4 Earnings Beat Estimates, Shares Up
Meritage Homes Corporation’s (MTH - Free Report) shares increased more than 7% in the after-hour trading session on Jan 29, post the company reported better-than-expected earnings in fourth-quarter 2019.
Earnings of $2.65 per share topped the Zacks Consensus Estimate of $1.92 by an impressive 38%. Also, the reported figure improved 39% year over year backed by solid home closing revenues, gross margins and greater overhead leverage. It also benefitted from retroactive energy tax credits recorded in 2019.
Total revenues (including Homebuilding and Financial Services revenues) amounted to $1,141.6 million, up 12.7% from year-ago quarter’s levels.
Meritage Homes Corporation Price, Consensus and EPS Surprise
Meritage Homes Corporation price-consensus-eps-surprise-chart | Meritage Homes Corporation Quote
Segment Discussion
Homebuilding/Total Closing Revenues: Revenues in the segment increased 12.7% from the prior-year quarter’s level to $1,136.8 million. Home closing revenues during the quarter amounted to $1,103.7 million, up 10.8% year over year. The upside can be attributed to a 13% increase in volumes, partially offset by 2% reduction in average sales price or ASP due to its strategic shift toward more affordable homes.
Home closing revenues in the East and West regions were both up by 19% year over year. However, Central declined 8% year over year primarily due to lower communities opening in the reporetd quarter.
Homes closed during the fourth quarter came in at 2,830, up 13% year over year. Total orders increased 26.6% from the prior-year quarter’s levels to 2,093 homes, marking it strongest quarterly year-over-year growth. The value of net orders also increased 24.8% year over year to $804.1 million mainly due to 37% higher absorption rate backed by rise in demand for its entry-level priced LiVE.NOW. homes.
However average community count fell 8% year on year, owing to early close-outs of communities in 2019. Active communities as of Dec 31, 2019 were 244, down from 272 homes reported in the year-ago quarter. Backlog at the end of the quarter totaled 2,782 units, up 14.3% year over year. Value of these backlogs also increased 8.1% year over year.
Home closing gross margin during the fourth quarter increased 80 basis points (bps) to 19.8% from year-ago quarter’s figure of 19%. This marked a contribution of 16% year-over-year increase to total home closing gross profit.
Moreover, land closing revenues amounted to $33.1 million, up 160% from $12.7 million in the year-ago quarter.
Financial Services: The segment’s revenues increased 7.8% from the prior-year quarter’s level to $4.7 million.
Operating Highlights
Selling, general and administrative expenses (as a percentage of home closing revenues) of 10.1% declined 50 bps from the prior-year quarter’s level of 10.6%.
Balance Sheet
As of Dec 31, 2019, cash and cash equivalents totaled $319.5 million compared with $311.5 million on Dec 31, 2018.
Debt-to-capital ratio at the end of 2019 was 34% compared with 43.2% at 2018-end. Also, net debt-to-capital ratio contracted to 26.2% from 36.7% on Dec 31, 2018.
2019 Highlights
Earnings per share for the year ended Dec 31, 2019 was reported at $6.42, up 15.1% from $5.58 reported in 2018.
Home closing gross margin increased 70 bps to 18.9% from 18.2% in 2018.
Total orders increased 19% year over year on the back of 37.3% increase in absorptions.
2020 Guidance
Given the company’s ability to deliver great value homes at modest prices along with positive economic drivers surrounding the housing market, the company is optimistic about future growth and success. It expects earnings to increase faster than its top-line growth in 2020, leveraging the operating improvements that were made earlier with further expansion and refinement.
For 2020, the company expects total home closings in the range of 9,700-10,200 units that suggests an increase from 9,267 units reported on Dec 31, 2019. Also, Meritage Homes expects ASPs in the range of $360,000 -370,000 that indicates a rise from $389,000 reported last year. Home closing gross margin is expected in the mid-19 percent, while tax rate is expected at approximately 22%.
Zacks Rank & Peer Releases
Meritage Homes currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
KB Home (KBH - Free Report) reported fourth-quarter fiscal 2019 results, with earnings beating analysts’ expectation and revenues missing the same. The quarterly results primarily benefited from strong demand for its built-to-order products at affordable price points along with higher deliveries. Moreover, the company’s top and the bottom line increased year over year by 15.6% and 36%, respectively.
PulteGroup Inc. (PHM - Free Report) reported better-than-expected fourth-quarter fiscal 2019 (ended Dec 31, 2019) results. Higher demand owing to favorable housing dynamics, backed by lower interest rates and improved affordability, had a positive impact on PulteGroup’s performance in the quarter.
D.R. Horton, Inc. (DHI - Free Report) reported first-quarter fiscal 2020 results, with earnings and revenues beating respective Zacks Consensus Estimate. Solid demand, limited supply of homes at affordable prices across the markets served, favorable economic fundamentals and financing availability. Also, 30,200 homes in inventory (at the end of December) make D.R. Horton well positioned for the spring selling season.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>